HEADER TRANSPORT PROTEIN 02-APR-21 7EJR TITLE CRYSTAL STRUCTURE OF V30M MUTATED TRANSTHYRETIN IN COMPLEX WITH 8- TITLE 2 CHLORO-9-OXO-9H-XANTHENE-3-CARBOXYLIC ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRANSTHYRETIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ATTR,PREALBUMIN,TBPA; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TTR, PALB; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS AMYLOIDOSIS, INHIBITOR, COMPLEX, TRANSPORT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR R.KITAKAMI,T.YOKOYAMA,M.MIZUGUCHI REVDAT 2 29-NOV-23 7EJR 1 REMARK REVDAT 1 13-OCT-21 7EJR 0 JRNL AUTH R.KITAKAMI,K.INUI,Y.NAKAGAWA,Y.SAWAI,W.KATAYAMA,T.YOKOYAMA, JRNL AUTH 2 T.OKADA,K.KANAMITSU,S.NAKAGAWA,N.TOYOOKA,M.MIZUGUCHI JRNL TITL INHIBITORY ACTIVITIES OF ANTHRAQUINONE AND XANTHONE JRNL TITL 2 DERIVATIVES AGAINST TRANSTHYRETIN AMYLOIDOGENESIS. JRNL REF BIOORG.MED.CHEM. V. 44 16292 2021 JRNL REFN ESSN 1464-3391 JRNL PMID 34225167 JRNL DOI 10.1016/J.BMC.2021.116292 REMARK 2 REMARK 2 RESOLUTION. 1.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.12_2829: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.43 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 41002 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.194 REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.208 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2050 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 31.4290 - 3.5769 1.00 2786 146 0.1829 0.2008 REMARK 3 2 3.5769 - 2.8396 1.00 2670 141 0.1943 0.1848 REMARK 3 3 2.8396 - 2.4809 1.00 2634 138 0.1984 0.2252 REMARK 3 4 2.4809 - 2.2541 1.00 2624 138 0.1975 0.2174 REMARK 3 5 2.2541 - 2.0926 1.00 2578 136 0.1892 0.2103 REMARK 3 6 2.0926 - 1.9692 1.00 2618 138 0.1906 0.1796 REMARK 3 7 1.9692 - 1.8706 1.00 2594 137 0.1922 0.2026 REMARK 3 8 1.8706 - 1.7892 1.00 2574 135 0.2008 0.2358 REMARK 3 9 1.7892 - 1.7203 1.00 2568 135 0.2138 0.2284 REMARK 3 10 1.7203 - 1.6610 1.00 2589 136 0.2020 0.2349 REMARK 3 11 1.6610 - 1.6090 1.00 2565 135 0.1992 0.2318 REMARK 3 12 1.6090 - 1.5630 1.00 2559 135 0.1995 0.2398 REMARK 3 13 1.5630 - 1.5219 1.00 2584 136 0.2114 0.2192 REMARK 3 14 1.5219 - 1.4848 1.00 2562 135 0.2181 0.2328 REMARK 3 15 1.4848 - 1.4510 0.96 2447 129 0.2374 0.2516 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.140 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.340 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 1908 REMARK 3 ANGLE : 0.941 2615 REMARK 3 CHIRALITY : 0.084 290 REMARK 3 PLANARITY : 0.006 334 REMARK 3 DIHEDRAL : 22.423 702 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7EJR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 12-APR-21. REMARK 100 THE DEPOSITION ID IS D_1300021610. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-NOV-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-17A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41002 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.450 REMARK 200 RESOLUTION RANGE LOW (A) : 35.470 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.50 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 4N85 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 25.58 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.65 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG400, CACL2, NAOAC, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 21.06950 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.96450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.06950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.96450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B 304 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -31 REMARK 465 ARG A -30 REMARK 465 GLY A -29 REMARK 465 SER A -28 REMARK 465 HIS A -27 REMARK 465 HIS A -26 REMARK 465 HIS A -25 REMARK 465 HIS A -24 REMARK 465 HIS A -23 REMARK 465 HIS A -22 REMARK 465 GLY A -21 REMARK 465 SER A -20 REMARK 465 MET A -19 REMARK 465 ALA A -18 REMARK 465 SER A -17 REMARK 465 HIS A -16 REMARK 465 ARG A -15 REMARK 465 LEU A -14 REMARK 465 LEU A -13 REMARK 465 LEU A -12 REMARK 465 LEU A -11 REMARK 465 CYS A -10 REMARK 465 LEU A -9 REMARK 465 ALA A -8 REMARK 465 GLY A -7 REMARK 465 LEU A -6 REMARK 465 VAL A -5 REMARK 465 PHE A -4 REMARK 465 VAL A -3 REMARK 465 SER A -2 REMARK 465 GLU A -1 REMARK 465 ALA A 0 REMARK 465 GLY A 1 REMARK 465 PRO A 2 REMARK 465 THR A 3 REMARK 465 GLY A 4 REMARK 465 THR A 5 REMARK 465 GLY A 6 REMARK 465 GLU A 7 REMARK 465 SER A 8 REMARK 465 LYS A 9 REMARK 465 PRO A 125 REMARK 465 LYS A 126 REMARK 465 MET B -31 REMARK 465 ARG B -30 REMARK 465 GLY B -29 REMARK 465 SER B -28 REMARK 465 HIS B -27 REMARK 465 HIS B -26 REMARK 465 HIS B -25 REMARK 465 HIS B -24 REMARK 465 HIS B -23 REMARK 465 HIS B -22 REMARK 465 GLY B -21 REMARK 465 SER B -20 REMARK 465 MET B -19 REMARK 465 ALA B -18 REMARK 465 SER B -17 REMARK 465 HIS B -16 REMARK 465 ARG B -15 REMARK 465 LEU B -14 REMARK 465 LEU B -13 REMARK 465 LEU B -12 REMARK 465 LEU B -11 REMARK 465 CYS B -10 REMARK 465 LEU B -9 REMARK 465 ALA B -8 REMARK 465 GLY B -7 REMARK 465 LEU B -6 REMARK 465 VAL B -5 REMARK 465 PHE B -4 REMARK 465 VAL B -3 REMARK 465 SER B -2 REMARK 465 GLU B -1 REMARK 465 ALA B 0 REMARK 465 GLY B 1 REMARK 465 PRO B 2 REMARK 465 THR B 3 REMARK 465 GLY B 4 REMARK 465 THR B 5 REMARK 465 GLY B 6 REMARK 465 GLU B 7 REMARK 465 SER B 8 REMARK 465 LYS B 9 REMARK 465 PRO B 125 REMARK 465 LYS B 126 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 44 -50.01 -121.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 201 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU A 66 OE1 REMARK 620 2 ASP A 99 O 95.2 REMARK 620 3 ASP A 99 OD1 82.7 70.4 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA B 201 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU B 66 OE1 REMARK 620 2 ASN B 98 OD1 73.8 REMARK 620 3 HOH B 310 O 146.1 83.7 REMARK 620 4 HOH B 368 O 79.6 87.0 124.9 REMARK 620 N 1 2 3 DBREF 7EJR A -19 126 UNP P02766 TTHY_HUMAN 1 146 DBREF 7EJR B -19 126 UNP P02766 TTHY_HUMAN 1 146 SEQADV 7EJR MET A -31 UNP P02766 INITIATING METHIONINE SEQADV 7EJR ARG A -30 UNP P02766 EXPRESSION TAG SEQADV 7EJR GLY A -29 UNP P02766 EXPRESSION TAG SEQADV 7EJR SER A -28 UNP P02766 EXPRESSION TAG SEQADV 7EJR HIS A -27 UNP P02766 EXPRESSION TAG SEQADV 7EJR HIS A -26 UNP P02766 EXPRESSION TAG SEQADV 7EJR HIS A -25 UNP P02766 EXPRESSION TAG SEQADV 7EJR HIS A -24 UNP P02766 EXPRESSION TAG SEQADV 7EJR HIS A -23 UNP P02766 EXPRESSION TAG SEQADV 7EJR HIS A -22 UNP P02766 EXPRESSION TAG SEQADV 7EJR GLY A -21 UNP P02766 EXPRESSION TAG SEQADV 7EJR SER A -20 UNP P02766 EXPRESSION TAG SEQADV 7EJR MET A 30 UNP P02766 VAL 50 VARIANT SEQADV 7EJR MET B -31 UNP P02766 INITIATING METHIONINE SEQADV 7EJR ARG B -30 UNP P02766 EXPRESSION TAG SEQADV 7EJR GLY B -29 UNP P02766 EXPRESSION TAG SEQADV 7EJR SER B -28 UNP P02766 EXPRESSION TAG SEQADV 7EJR HIS B -27 UNP P02766 EXPRESSION TAG SEQADV 7EJR HIS B -26 UNP P02766 EXPRESSION TAG SEQADV 7EJR HIS B -25 UNP P02766 EXPRESSION TAG SEQADV 7EJR HIS B -24 UNP P02766 EXPRESSION TAG SEQADV 7EJR HIS B -23 UNP P02766 EXPRESSION TAG SEQADV 7EJR HIS B -22 UNP P02766 EXPRESSION TAG SEQADV 7EJR GLY B -21 UNP P02766 EXPRESSION TAG SEQADV 7EJR SER B -20 UNP P02766 EXPRESSION TAG SEQADV 7EJR MET B 30 UNP P02766 VAL 50 VARIANT SEQRES 1 A 158 MET ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER MET SEQRES 2 A 158 ALA SER HIS ARG LEU LEU LEU LEU CYS LEU ALA GLY LEU SEQRES 3 A 158 VAL PHE VAL SER GLU ALA GLY PRO THR GLY THR GLY GLU SEQRES 4 A 158 SER LYS CYS PRO LEU MET VAL LYS VAL LEU ASP ALA VAL SEQRES 5 A 158 ARG GLY SER PRO ALA ILE ASN VAL ALA MET HIS VAL PHE SEQRES 6 A 158 ARG LYS ALA ALA ASP ASP THR TRP GLU PRO PHE ALA SER SEQRES 7 A 158 GLY LYS THR SER GLU SER GLY GLU LEU HIS GLY LEU THR SEQRES 8 A 158 THR GLU GLU GLU PHE VAL GLU GLY ILE TYR LYS VAL GLU SEQRES 9 A 158 ILE ASP THR LYS SER TYR TRP LYS ALA LEU GLY ILE SER SEQRES 10 A 158 PRO PHE HIS GLU HIS ALA GLU VAL VAL PHE THR ALA ASN SEQRES 11 A 158 ASP SER GLY PRO ARG ARG TYR THR ILE ALA ALA LEU LEU SEQRES 12 A 158 SER PRO TYR SER TYR SER THR THR ALA VAL VAL THR ASN SEQRES 13 A 158 PRO LYS SEQRES 1 B 158 MET ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER MET SEQRES 2 B 158 ALA SER HIS ARG LEU LEU LEU LEU CYS LEU ALA GLY LEU SEQRES 3 B 158 VAL PHE VAL SER GLU ALA GLY PRO THR GLY THR GLY GLU SEQRES 4 B 158 SER LYS CYS PRO LEU MET VAL LYS VAL LEU ASP ALA VAL SEQRES 5 B 158 ARG GLY SER PRO ALA ILE ASN VAL ALA MET HIS VAL PHE SEQRES 6 B 158 ARG LYS ALA ALA ASP ASP THR TRP GLU PRO PHE ALA SER SEQRES 7 B 158 GLY LYS THR SER GLU SER GLY GLU LEU HIS GLY LEU THR SEQRES 8 B 158 THR GLU GLU GLU PHE VAL GLU GLY ILE TYR LYS VAL GLU SEQRES 9 B 158 ILE ASP THR LYS SER TYR TRP LYS ALA LEU GLY ILE SER SEQRES 10 B 158 PRO PHE HIS GLU HIS ALA GLU VAL VAL PHE THR ALA ASN SEQRES 11 B 158 ASP SER GLY PRO ARG ARG TYR THR ILE ALA ALA LEU LEU SEQRES 12 B 158 SER PRO TYR SER TYR SER THR THR ALA VAL VAL THR ASN SEQRES 13 B 158 PRO LYS HET CA A 201 1 HET J5R A 202 19 HET CA B 201 1 HET J5R B 202 19 HETNAM CA CALCIUM ION HETNAM J5R 8-CHLORANYL-9-OXIDANYLIDENE-XANTHENE-3-CARBOXYLIC ACID FORMUL 3 CA 2(CA 2+) FORMUL 4 J5R 2(C14 H7 CL O4) FORMUL 7 HOH *175(H2 O) HELIX 1 AA1 ASP A 74 LEU A 82 1 9 HELIX 2 AA2 ASP B 74 LEU B 82 1 9 SHEET 1 AA1 8 SER A 23 PRO A 24 0 SHEET 2 AA1 8 LEU A 12 ASP A 18 -1 N ASP A 18 O SER A 23 SHEET 3 AA1 8 ARG A 104 SER A 112 1 O ILE A 107 N MET A 13 SHEET 4 AA1 8 SER A 115 THR A 123 -1 O THR A 123 N ARG A 104 SHEET 5 AA1 8 SER B 115 THR B 123 -1 O THR B 118 N TYR A 116 SHEET 6 AA1 8 ARG B 104 SER B 112 -1 N ARG B 104 O THR B 123 SHEET 7 AA1 8 LEU B 12 ASP B 18 1 N LEU B 17 O LEU B 111 SHEET 8 AA1 8 SER B 23 PRO B 24 -1 O SER B 23 N ASP B 18 SHEET 1 AA2 8 GLU A 54 LEU A 55 0 SHEET 2 AA2 8 LEU A 12 ASP A 18 -1 N VAL A 14 O LEU A 55 SHEET 3 AA2 8 ARG A 104 SER A 112 1 O ILE A 107 N MET A 13 SHEET 4 AA2 8 SER A 115 THR A 123 -1 O THR A 123 N ARG A 104 SHEET 5 AA2 8 SER B 115 THR B 123 -1 O THR B 118 N TYR A 116 SHEET 6 AA2 8 ARG B 104 SER B 112 -1 N ARG B 104 O THR B 123 SHEET 7 AA2 8 LEU B 12 ASP B 18 1 N LEU B 17 O LEU B 111 SHEET 8 AA2 8 GLU B 54 LEU B 55 -1 O LEU B 55 N VAL B 14 SHEET 1 AA3 8 TRP A 41 LYS A 48 0 SHEET 2 AA3 8 ALA A 29 LYS A 35 -1 N VAL A 32 O ALA A 45 SHEET 3 AA3 8 GLY A 67 ILE A 73 -1 O GLU A 72 N HIS A 31 SHEET 4 AA3 8 HIS A 88 ALA A 97 -1 O ALA A 91 N ILE A 73 SHEET 5 AA3 8 HIS B 88 ALA B 97 -1 O GLU B 89 N VAL A 94 SHEET 6 AA3 8 GLY B 67 ILE B 73 -1 N ILE B 73 O ALA B 91 SHEET 7 AA3 8 ALA B 29 LYS B 35 -1 N HIS B 31 O GLU B 72 SHEET 8 AA3 8 TRP B 41 LYS B 48 -1 O ALA B 45 N VAL B 32 LINK OE1 GLU A 66 CA CA A 201 1555 1555 2.37 LINK O ASP A 99 CA CA A 201 1555 1555 2.56 LINK OD1 ASP A 99 CA CA A 201 1555 1555 2.43 LINK OE1 GLU B 66 CA CA B 201 1555 1555 2.57 LINK OD1 ASN B 98 CA CA B 201 1555 1555 2.39 LINK CA CA B 201 O HOH B 310 1555 4554 2.34 LINK CA CA B 201 O HOH B 368 1555 1555 2.21 CRYST1 42.139 85.929 62.858 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023731 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011638 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015909 0.00000